CORT vs SNPS · P/E 199, rev $421.1M vs P/E 63, rev $7.16B
Corcept Therapeutics Incorporated (CORT) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the CORT and SNPS stock pages for the full models.
Not investment advice.